Caraco Stockholders Approve Merger With Parent Sun PharmaDetroit-based Caraco Pharmaceutical Laboratories Inc. will shortly cease operation as a publicly traded company.
Caraco Loss Flat Despite Lower SalesThe Detroit generic drug maker Caraco Pharmaceutical reported a loss of $3 million or eight cents a share in the third fiscal quarter of its fiscal year, ended Dec. 31, an improvement from a loss of $3.3 million or eight cents a share in the same quarter a year earlier despite a decline in revenue in the quarter to $40.4 million from $52 million a year earlier.
Caraco Pharmaceutical Names New CEO
HR Notices From September 15
Caraco Adds Two Generics